Coya Therapeutics, Inc. (COYA) Operating income 2021–2025
Coya Therapeutics, Inc. (COYA) annual operating income history from SEC filings — each fiscal year as reported.
-$22.6MFY2025 · since FY2021: -$4.9M → -$22.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$22.6M | -30.8% |
| FY2024 | -$17.2M | -118.3% |
| FY2023 | -$7.9M | +19.5% |
| FY2022 | -$9.8M | -101.5% |
| FY2021 | -$4.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More COYA financial trends
COYA RevenueCOYA Net incomeCOYA Net marginCOYA Gross profitCOYA Gross marginCOYA Operating marginCOYA Operating cash flowCOYA Free cash flowCOYA Capital expendituresCOYA Return on equityCOYA Stock buybacksCOYA Dividends paidCOYA Total assetsCOYA Total liabilitiesCOYA Shareholders’ equityCOYA overview →